Ken Griffin’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-329,964
Closed -$187K 6279
2025
Q1
$187K Buy
329,964
+261,248
+380% +$148K ﹤0.01% 4900
2024
Q4
$145K Sell
68,716
-47,278
-41% -$99.8K ﹤0.01% 5025
2024
Q3
$312K Sell
115,994
-9,375
-7% -$25.2K ﹤0.01% 4252
2024
Q2
$357K Buy
125,369
+106,383
+560% +$303K ﹤0.01% 4135
2024
Q1
$80.5K Buy
+18,986
New +$80.5K ﹤0.01% 5162
2023
Q4
Sell
-1,890
Closed -$8.13K 6210
2023
Q3
$8.13K Sell
1,890
-1,876
-50% -$8.07K ﹤0.01% 5471
2023
Q2
$20.7K Sell
3,766
-26,861
-88% -$147K ﹤0.01% 5244
2023
Q1
$129K Sell
30,627
-11,447
-27% -$48.1K ﹤0.01% 4821
2022
Q4
$117K Buy
42,074
+26,839
+176% +$74.3K ﹤0.01% 4952
2022
Q3
$39K Sell
15,235
-133,708
-90% -$342K ﹤0.01% 5388
2022
Q2
$537K Buy
148,943
+128,839
+641% +$465K ﹤0.01% 4066
2022
Q1
$125K Buy
+20,104
New +$125K ﹤0.01% 5533
2021
Q4
Sell
-12,645
Closed -$88K 6743
2021
Q3
$88K Buy
+12,645
New +$88K ﹤0.01% 5929
2021
Q2
Sell
-13,033
Closed -$71K 6670
2021
Q1
$71K Buy
+13,033
New +$71K ﹤0.01% 5997
2020
Q3
Sell
-44,884
Closed -$139K 4906
2020
Q2
$139K Buy
+44,884
New +$139K ﹤0.01% 4172
2019
Q3
Sell
-58,670
Closed -$118K 4864
2019
Q2
$118K Buy
+58,670
New +$118K ﹤0.01% 4249
2018
Q4
Sell
-59,833
Closed -$314K 4683
2018
Q3
$314K Buy
+59,833
New +$314K ﹤0.01% 3466
2018
Q2
Sell
-12,809
Closed -$64K 4336
2018
Q1
$64K Buy
+12,809
New +$64K ﹤0.01% 3706
2016
Q2
Sell
-26,678
Closed -$81K 3568
2016
Q1
$81K Buy
+26,678
New +$81K ﹤0.01% 2925
2015
Q4
Sell
-15,051
Closed -$57K 4040
2015
Q3
$57K Sell
15,051
-1,111
-7% -$4.21K ﹤0.01% 3517
2015
Q2
$93K Buy
+16,162
New +$93K ﹤0.01% 3282
2014
Q3
Sell
-105,862
Closed -$482K 3603
2014
Q2
$482K Buy
105,862
+91,815
+654% +$418K ﹤0.01% 2306
2014
Q1
$67K Buy
14,047
+9,602
+216% +$45.8K ﹤0.01% 3184
2013
Q4
$21K Sell
4,445
-53,063
-92% -$251K ﹤0.01% 2868
2013
Q3
$229K Buy
57,508
+6,662
+13% +$26.5K ﹤0.01% 2248
2013
Q2
$183K Buy
+50,846
New +$183K ﹤0.01% 2290